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Abstract
Background According to many Societies’ guidelines,
patients presenting with clinical T4 colorectal cancer
should conventionally be approached by a laparotomy.
Results of emerging series are questioning this attitude.
Methods We retrospectively analysed the oncologic out-
comes of 147 patients operated on between June 2008 and
September 2015 for histologically proven pT4 colon can-
cers. All patients were treated with curative intent, either
by a laparoscopic or open ‘‘en bloc’’ resection.
Results Median operative time, blood loss and hospital
length of stay were significantly reduced in the laparo-
scopic group. Postoperative surgical complication rate and
30-day mortality did not significantly differ between the
two groups ( p = 0.09 and p = 0.99, respectively). R1
resection rate and lymph nodes harvest, as well, did not
remarkably differ when comparing the two groups. In the
laparoscopic group, conversion rate was 19%. Long-term
outcomes were not affected in patients who had undergone
conversion. Five-year overall survival and disease-free
survival did not significantly differ between the two groups
(44.6% and 40.3% vs. 39.4% and 38.9%). Locally
advanced stages (IIIB–IIIC) and R1 resections were
detected as independent prognostic factors for overall
survival.
Conclusion Laparoscopic approach might be safe and
acceptable for locally advanced colon cancer and does not
jeopardize the oncologic results. Conversion to open sur-
gery should be a part of a strategy as it does not seem to
adversely affect perioperative and long-term outcomes. We
consider laparoscopy, in expert hands, the last diagnostic
tool and the first therapeutic approach for well-selected
locally advanced colon cancers. Larger prospective studies
are needed to widely assess this issue.
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Colorectal cancer (CRC) accounts for 13% of all cancers, it
represents the third most common neoplasia and it stands
for the second leading cause of cancer death in the 27
countries of the European Union [1].
Jacobs et al. first reported the technical feasibility of the
laparoscopic colectomy in 1991 [2]; since then, many
randomized controlled trials and meta-analyses showed
laparoscopic colon resections for cancer (LCRC) being
safe and, at least, equivalent on long-term outcomes to the
open technique.
In experienced hands, LCRC may provide rates of R0
complete resection, lymph nodes retrieval and oncologic
outcomes comparable to open procedures [3–7]. In addition
to the notable perioperative advantages provided by
laparoscopy [8–10], a recent analysis suggested that LCRC
could provide even better long-term outcomes in ‘‘high-
risk’’ patients (C80 years, American Society of Anaesthe-
siologists C3, preoperative radiotherapy, T4 tumours and
BMI C30) compared to open resections [11].
Nowadays however, according to Societies’ guidelines,
patients affected by clinically staged T4 CRC should be
managed by an open approach [12, 13].
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2For several years, the laparoscopic multi-visceral dis-
section has been considered technically demanding, bur-
densome, lengthy and prone to excessively high conversion
rates. Moreover, some authors pointed out the correlation
between surgical conversion and increased rates of post-
operative morbidity and mortality [9]. Consequently, seri-
ous concerns rapidly raised about safety, technical
feasibility and oncologic results of the mini-invasive access
[14].
Conversely, emerging series are strongly questioning
this attitude. Technical skills’ development, recent instru-
mental advancements as well as appropriated patient
selection contributed to the extension of laparoscopic
working area.
Materials and methods
T4 colon cancer population study
We retrospectively collected 147 patients affected by
pT4N0-2M0 colon cancer, electively treated with curative
intent between June 2008 and September 2015 (Fig. 1).
Among them, 68 patients underwent laparoscopic surgical
resection and 79 patients were approached by conventional
laparotomy. According to the departmental directives, the
choice of surgical access was preoperative set mainly on
primary tumour location and on pattern of the nearby
organs’ infiltration. Previous major abdominal surgery and
severe medical conditions were minor reasons for direct
open approach.
Preoperative work-up consisted in complete biochem-
istry, tumour markers, colonoscopy and thoraco-abdominal
computer tomography (CT). Virtual CT colonoscopy was
performed in case of incomplete preoperative colonoscopy.
The following aspects were investigated: operative time,
blood loss, intra-operative complications, postoperative
outcomes (hospital length of stay, postoperative compli-
cations, perioperative blood loss, 30-day mortality rate,
time-frame before adjuvant chemotherapy), completeness
of the resection (R0–2), lymph nodes harvest, follow-up
period and survival (disease-free survival, overall survival,
recurrence rate).
Operative technique
In our surgical department, both conventional surgery and
standardized LCRC (right colectomies, segmental splenic
flexure resections and left colectomies) are commonly
performed since the 1990s.
None of the patients underwent PEG intestinal prepa-
ration. All patients were referred to low-fibre diet for
7 days before surgery. Patients with left side colon cancers
were subjected to liquid diet and two low-pressure enemas
the day before surgery.
All 147 patients underwent an ‘‘en bloc’’ surgical
resection, extended to tissues involved by the neoplasia.
Gentle dissection was conducted according to the rules of
the no-touch technique. A wall protector device was always
positioned. Surgical procedures routinely included the
proximal ligation of blood vessels and the removal of
lymphatic bearing segment.
Cancers located along the very distal transverse colon
and at the splenic flexure underwent segmental resection
with proximal ligation of the left colic and the left branch
of the middle colic arteries.
Conversion was defined as a laparotomy performed
during the laparoscopic operation, in order to ensure
complete resection, reconstruction or haemostasis and not
just for the specimen extraction.
Except for the first six laparoscopic right colectomies,
an intra-corporeal anastomosis construction was performed
for right-sided colon cancers. Closure of the enterotomies
was ensured using a double-layer slow-absorbable running
sutures.
Postoperative protocols included epidural analgesia for
2 days, liquid fluid diet and gum chewing on first postop-
erative day, and semisolid diet on second postoperative
Fig. 1 Flow chart showing patient selection
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3day. No naso-gastric tube was left in place. Urinary bladder
catheter was removed on the first postoperative day, except
in patients who had undergone bladder resection. The intra-
abdominal drain, when left in place, was removed on
second postoperative day.
Histopathological examination
Histopathological examination included assessment of wall
depth of invasion (T stage), N stage, distal margin status
and number of lymph nodes harvest.
Resections were generally defined as R0 resection
(negative microscopic margins), R1 resection (positive
microscopic margins without gross residual disease) and
R2 resection (incomplete resection with gross residual
disease).
Follow-up
All patients were postoperatively referred to the Oncologist
for adjuvant chemotherapy.
According to European guidelines, patients were sub-
jected to 5-year surveillance program consisting in physical
examination and tumour markers (CEA and CA 19.9)
dosage every 3 months for the first year and then every
6 months. Complete colonoscopies were recommended at
one and three years after the operation. Thoracic and
abdominal CT scan were planned every 6 months for
3 years and once a year for the following 2 years of
surveillance.
Statistical analysis
Quantitative data are reported as mean, median, standard
deviation (SD) and interquartile range (25–75%). Qual-
itative variables are expressed as absolute frequencies and
percentages. Differences in categorical data were compared
using v2 (or Fisher’s exact test when appropriated); dif-
ferences in continuous variables were compared using
Student t test or Mann–Whitney test. Univariate analyses of
overall survival (OS) and disease-free survival (DFS) rates
were performed using the Kaplan–Meyer method. Differ-
ences when comparing survival curves were analysed using
the Log-Rank test (Mantel Cox). Cox regression analysis
was performed in order to identify possible prognostic
factors with adjustment for confounders. Results are
reported as Hazard Ratio (HR) [95% confidence interval
(C.I.)]. A level of 5% was set as the criterion for statistical
significance. Statistical analyses were carried out using
software R (the R Foundation for Statistical Computing;
Version 3.0.3).
Results
Over a 7-year period, 147 patients affected by pT4N0-2M0
colon cancers underwent curative multi-visceral resection in
our General SurgeryDepartment in Naples. Among them, 68
were LCRC, while 79 were approached by a laparotomy.
Groups were comparable as far as age, gender, BMI,
ASA score, tumour localization and previous surgery were
concerned (Table 1).
Sundry organs and tissues resulted infiltrated by T4
colon cancers: small bowel, abdominal wall, duodenal-
pancreatic block, Gerota fascia and the retroperitoneum
(see Table 2).
Median operative time was 150 min. Laparoscopic
operations resulted to be slightly faster than open ones (see
Table 3). Median blood loss was 270 ml. Blood loss and
hospital length of stay were significantly reduced in the
laparoscopic group.
Conversion to open surgery concerned 13 patients
(19%): nine patients underwent conversion to safely
achieve complete resection, three patients for organ
reconstruction (one ureter re-implant and two duodenal
resections) and in one case conversion was required to
control an uneasy splenic bleeding.
Postoperative surgical complication rate did not signif-
icantly differ between the two groups (p = 0.09), but were
less frequent in the laparoscopic group. Surgical site
infections occurred in 11 patients (7.5%). Digestive
bleeding occurred in four patients (2.7%): two of them
required blood transfusions and there was no need for re-
operation. Clinical signs of anastomotic leak occurred in
three patients (2%), who underwent re-operation.
No significant differences in postoperative morbidity were
detected when comparing patients who had undergone con-
verted and totally laparoscopic colonic resections (p = 0.99).
The 30-day mortality rate was 2%. No differences in
mortality rate were detected when comparing the two
groups (p = 0.99). In the laparoscopic group, one patient
died for septic complications. In the open one, two patients
died for a fulminant myocardial infarction and for a mas-
sive pulmonary embolism.
Complete R0 resection was achieved in 88% of the cases
in both groups. In the laparoscopic group, the subgroup of
converted patients presented an R0 resection rate of 85%,
while the totally laparoscopic one of 89%. Median number
of lymph nodes harvest in the specimen was 17.4 (±3.9)
and 16.3 (±3.7), respectively, for the open and the
laparoscopic group. The number of lymph node yield
higher than 12 was achieved in all open resections and in
96% of laparoscopic resections. Other oncological features
are shown in Table 4.
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4Table 1 Patients’ features
Laparoscopic (N = 68) Open (N = 79) p value
Age 0.57
Mean ± SD 67 ± 11 66 ± 9
Median [25–75%] 68 [59–74] 65 [59–72]
Sex 0.81
Male 40 (58.8%) 48 (60.8%)
Female 28 (41.2%) 31 (39.2%)
BMI 0.95
Mean ± SD 27 ± 3 27 ± 3
Median [25–75%] 27 [25–28] 27 [25–28]
ASA score 0.72
I 4 (5.9%) 7 (8.9%)
II 50 (73.5%) 54 (68.4%)
III 14 (20.6%) 18 (22.75)
Tumour location site 0.99
Right colon 18 (26.5%) 21 (26.6%)
Distal transverse colon 7 (10.3%) 8 (10.1%)
Left colon 43 (63.2%) 50 (63.3%)
Previous surgery 7 (10.1%) 15 (18.9%) 0.14
Table 2 Organs involved by
the T4 colonic tumours
Laparoscopic group Open group
Small bowel (except duodenum) 26 32
Abdominal wall 23 24
Duodenal-pancreatic block and pancreatic tail 2 9
Gerota and retroperitoneum 4 9
Bladder 7 3
Gynecologic organs 6 1
Liver/gallbladder/stomach 5 3
Table 3 Perioperative
outcomes in laparoscopic and
open groups
Laparoscopic (N = 68) Open (N = 79) p value
Type of surgery 0.99
(Extended) right colectomy 18 (26.5%) 21 (26.6%)
Segmental splenic flexure resection 7 (10.3%) 8 (10.1%)
Left colectomy 43 (63.2%) 50 (63.3%)
Operative time (min)
Median [25–75%] 140 [125–160] 160 [140–170] 0.001*
Blood loss (ml)
Median [25–75%] 200 [170–250] 350 [280–450] p\ 0.001*
Length of hospital stay (days)
Median [25–75%] 8 [7–9] 9 [9–11] p\ 0.001*
Postoperatory morbidity 5 (7.4%) 13(16.5%) 0.09
Clavien-dindo classification 0.99
II 4 (80.0%) 9 (69.2%)
III 1 (20.0%) 4 (30.8%)
Mortality within 30 days 1 (1.5%) 2 (2.5%) 0.99
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5None of the patients received preoperative chemotherapy,
while more than 75% of them benefited from adjuvant
chemotherapy (mainly XELOX or FOLFOX regimes). No
difference in rate of patients who had undergone adjuvant
treatment was detected when comparing the two groups
(p = 0.85).
Median time-frame between surgery and chemotherapy
was 36 days (min 28, max 47 days), slightly prolonged in
the open group.
Five-year overall survival was 44.6% in the laparoscopic
group [CI 32.8–60.6%] and 39.4% in the open group [CI
28.3–55.0%], with no statistical difference detected (see
Fig. 2).
Five-year disease-free survival did not differ between
the two groups (40.3% in the laparoscopic group, [CI
29.2–55.8%] vs. 38.9% of the open group, [CI
28.8–52.5%], p = 0.99) (see Fig. 3).
In the laparoscopic group, no significant differences in
both 5-year overall survival (45.8%, [CI 33.3–62.9%] vs.
46.2%, [CI 22.1–84.0%], p = 0.79) and 5-year disease-free
survival (40.2%, [CI 28.8–57.7%] vs. 43.1%, [CI
23.6–90.4%], p = 0.86) were detected between patients
who underwent converted colectomies versus totally
laparoscopic ones.
Advanced cancer stage (IIIB–IIIC) and R1 margins were
independent factors associated with poorer overall survival.
Fig. 2 Overall survival in the compared groups Fig. 3 Disease-free survival in the compared groups
Table 4 Pathologic features
and oncologic outcomes in
laparoscopic and open groups
Laparoscopic (N = 68) Open (N = 79) p value
pTNM stage 0.90
IIB 33 (48.5%) 36 (45.6%)
IIIB 27 (39.7%) 32 (40.5%)
IIIC 8 (11.8%) 11 (13.9%)
Margin status 0.87
R0 60 (88.2%) 69 (88.5%)
R1 8 (11.8%) 10 (11.5%)
Lymph node harvest 0.07
Median [25–75%] 15 [14–18] 17 [15–20]
Adjuvant therapy 0.85
Yes 53 (77.9%) 60 (75.9%)
No 15 (22.1%) 19 (24.1%)
Status of patient at the end of follow-up 0.91
Alive 36 (52.9%) 40 (50.6%)
Died 32 (47.1%) 39 (49.4%)
Recurrences at the end of follow-up 0.87
No 32 (47.1%) 35 (44.3%)
Yes 36 (52.9%) 44 (55.7%)
Follow-up (months) 0.62
Median [25–75%] 37 [24–55] 34 [25–46]
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6Advanced cancer stage was as well independent prognostic
factor for impaired disease-free survival in our analysis
(see Tables 5, 6).
Discussion
The surgical treatment of colorectal malignancy has pro-
foundly been changed, in recent years, by the advent of
laparoscopy.
Multicentre randomized trials provided extensive evi-
dence of safety and feasibility of colonic resection per-
formed through a mini-invasive access. Moreover, LCRC
implied notable advantages in terms of perioperative out-
comes when compared to open surgery [8–10]. Recent
series have even shown improved long-term outcomes in
patients who had undergone LCRC rather than conven-
tional ones, in high volume centres [7]. An improvement in
survival was mainly noticed in patients affected by colon
cancer staged III according to AJCC (American Join
Committee on Cancer) classification [11]. Among reasons
advocated to justify better survival, the less compromised
immunological response of patients undergoing laparo-
scopic resections was ascribed [15, 16].
International guidelines have long been recommending
to approach locally advanced colonic cancer, a priori, by a
laparotomy [12, 13]. International recommendations,
however, do not take into consideration important technical
evolution and instrumental advancements, which led to
very encouraging oncological results [15–19].
At the beginning, in fact, concerns were raised about
technical feasibility of the laparoscopic multi-visceral
dissection, safe control of intra-operative complications as
haemorrhages and operative time prolongation. Moreover,
a higher rate of conversion to open surgery was expected,
leading to morbidity, mortality and impairment of the
oncologic outcome.
As a matter of facts, in CLASICC trial [9], a significant
increase in morbidity (69% vs. 47%) and mortality (9% vs.
1%) were recorded in patients who had undergone con-
version to open surgery. Some other authors reported
adversely affected short- and long-term outcomes in
patients who had undergone surgical conversion [9, 20].
Conversely, several series reported no difference in mor-
bidity and/or in mortality whether or not conversion hap-
pened in patients affected by colon cancer [21–24].
Conversions reported in the literature ranged from 7.9 to
49% [14, 16, 19, 25].
In our series, conversion rate concerned 13 patients
(19%). Among them, all but one was unattended for
bleeding, while in 12 patients, conversion was undertaken
as a result of an intra-operative decision.
We consider it indispensable to make the difference
between an unplanned conversion, needed, for example, to
obtain haemostasis in a sudden uncontrollable bleeding or
in cases of tumour infringement, and a conversion planned
on surgeon’s intra-operative evaluation in order to provide
a complete resection or reconstruction. In this context, as
emphasized by the guidelines [13], the high expertise of the
surgeon in LCRC disease is essential to approach locally
advanced disease.
In our analysis, perioperative outcomes in the subgroup
of patients who had undergone conversion were
Table 5 Cox multivariate regression analysis to identify possible
predictors of mortality in T4 patients (number of deaths: 71)
Variable Hazard ratio p value
Gender 0.60
Male 1.00 (reference)
Female 1.14 [0.69–1.89]
Age 0.40
\65 1.00 (reference)
C65 1.25 [0.75–2.09]
Surgery 0.50
Open 1.00 (reference)
Laparoscopy 1.18 [0.73–1.92]
Stage
IIB 1.00 (reference)
IIIB 3.47 [1.88–6.43] p\ 0.001**
IIIc 24.88 [10.88–56.85] p\ 0.001**
Margin status 0.04*
R0 1.00 (reference)
R1 2.05 [1–04–4.08]
Table 6 Cox multivariate regression analysis to identify possible
predictors of recurrences in T4 patients (number of recurrences: 80)
Variable Hazard ratio p value
Gender 0.16
Female 1.00 (reference)
Male 1.40 [0.87–2.24]
Age 0.66
\65 1.00 (reference)
C65 0.90 [0.57–1.43]
Surgery 0.08
Open 1.00 (reference)
Laparoscopy 1.51 [0.94–2.40]
Stage
IIB 1.00 (reference)
IIIB 3.60 [2.07–6.27] p\ 0.001**
IIIc 27.69 [12.32–62.23] p\ 0.001**
Margin status 0.12
R0 1.00 (reference)
R1 1.70 [0.87–3.29]
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7comparable to those of the open group. Furthermore, long-
term survival in converted group resulted not impaired.
Some short-term outcomes resulted significantly
improved in the laparoscopic group.
Less operative time was recorded in the mini-invasive
group. This result, discordant to current literature, might be
due to the high level of laparoscopic expertise achieved in
the department since the 1990s, partially to the 3-dimen-
sional high-definition technology available since 2013 and
more likely to the selection bias. Patients with more chal-
lenging dissection (as tumour invasion of the duodenal-
pancreatic block and the retroperitoneum) were preferably
approached by laparotomy.
In the laparoscopic group, less intra-operative blood loss
was recorded (p = 0.001). Blood loss has been demon-
strated to have a predictive role of long-term survival
[26, 27].
Hospital length of stay was significantly reduced in the
laparoscopic group, confirming that mini-invasiveness
permits faster recovery [8–10].
Morbidity and mortality rates were comparable between
the two groups, but less frequent in the laparoscopic one.
A proper resection margin (R0) is known to be the most
important prognostic factor of long-term survival [28, 29].
Cox multivariate analyses in our series detected marginal
status (R) and advanced AJCC stage as independent pre-
dictors of long-term mortality.
In the literature, a wide range of R1 open resections for
T4 lesions is reported, reaching up to 50%. Data on
laparoscopic resections are scarce: in COLOR trial, R1
resections among patients affected by T4 colorectal cancers
reached 20%, while Bretagnol et al. reported 13% [9, 25].
Complete R0 resection was achieved in 88% of the cases
in both groups. R0 resection rate was 89% in the subgroup
of totally LCRC and 85% in the subgroup of converted
patients. This difference, testifying the difficulty of dis-
section of the converted cases and the conversion strategy
adopted [30], did not translate into worst short- and long-
term results.
Histopathological examination of the specimen con-
firmed an adequate median number of lymph node retrieval
in the both groups.
No negative impact on oncologic outcome was detected
in the presence of a small, not significant, difference in
lymph node harvest detected between the two groups
(p = 0.07). All patients approached conventionally had
lymph node yield greater than 12, while this occurred in all
but three patients in the laparoscopic group, whose yield
was 10 for one and 11 for two of them.
Finally, no differences in 5-year overall survival
(p = 0.99) and in 5-year disease-free survival (p = 0.79)
were observed when comparing the two groups, suggesting
that laparoscopy might be a valid and effective tool to
approach locally advanced colon cancer without jeopardize
oncologic results, in accordance with previous series
reported [15–17, 19, 25–28, 31].
Limits of this study are inhered to the single-centre
retrospective design and to patient’s selection bias. This
approach, however, allowed us to safely provide an
extention of the laparoscopic resection’s indication for
locally advanced colon cancers.
Conclusion
Laparoscopic approach might be safe and acceptable for
locally advanced colon cancer and does not jeopardize the
oncologic results in well-selected patients. Conversion to
open surgery should be a part of a strategy as it does not
seem to adversely affect perioperative and long-term out-
comes. We consider laparoscopy, in expert hands, the last
diagnostic tool and the first therapeutic approach for well-
selected locally advanced colon cancers. Larger prospec-
tive studies are needed to widely assess this issue.
Compliance with ethical standards
Disclosure Drs. Piera Leon, Michele Giuseppe Iovino, Fabiola
Giudici, Antonio Sciuto, Nicolo` de Manzini, Diego Cuccurullo and
Francesco Corcione have no conflicts of interest or financial ties to
disclose.
References
1. Ferlay J et al (2013) Cancer incidence and mortality patterns in
Europe: estimates for 40 countries in 2012. Eur J Cancer 49(6):
1374–1403
2. Jacobs M, Verdeja JC, Goldstein HS (1991) Minimally invasive
colon resection (laparoscopic colectomy). Surg Laparosc Endosc
1(3):144–150
3. Capussotti L et al (2004) Laparoscopy as a prognostic factor in
curative resection for node positive colorectal cancer: results for a
single-institution nonrandomized prospective trial. Surg Endosc
18(7):1130–1135
4. Bilimoria KY et al (2008) Use and outcomes of laparoscopic-
assisted colectomy for cancer in the United States. Arch Surg
143(9):832–839 discussion 839–840
5. Lacy AM et al (2008) The long-term results of a randomized
clinical trial of laparoscopy-assisted versus open surgery for
colon cancer. Ann Surg 248(1):1–7
6. Law WL et al (2012) Survival following laparoscopic versus
open resection for colorectal cancer. Int J Colorectal Dis
27(8):1077–1085
7. Huscher CG, Bretagnol F, Corcione F (2015) Laparoscopic col-
orectal cancer resection in high-volume surgical centers: long-
term outcomes from the lapcolon group trial. World J Surg
39(8):2045–2051
8. Veldkamp R et al (2005) Laparoscopic surgery versus open
surgery for colon cancer: short-term outcomes of a randomised
trial. Lancet Oncol 6(7):477–484
9. Guillou PJ et al (2005) Short-term endpoints of conventional
versus laparoscopic-assisted surgery in patients with colorectal
Surg Endosc (2018) 32:1133–1140 1139
123
8cancer (MRC CLASICC trial): multicentre, randomised con-
trolled trial. Lancet 365(9472):1718–1726
10. Braga M et al (2002) Laparoscopic versus open colorectal sur-
gery: a randomized trial on short-term outcome. Ann Surg
236(6):759–766 (discussion 767)
11. Hemandas AK et al (2010) Laparoscopic colorectal surgery
produces better outcomes for high risk cancer patients compared
to open surgery. Ann Surg 252(1):84–89
12. Veldkamp R et al (2004) Laparoscopic resection of colon Cancer:
consensus of the European Association of Endoscopic Surgery
(EAES). Surg Endosc 18(8):1163–1185
13. Society of American Gastrointestinal and Endoscopic Surgeons
(SAGES) (2012) Guidelines for laparoscopic resection of curable
colon and rectal cancer. https://www.sages.org/publications/guid
elines/guidelines-for-laparoscopic-resection-of-curable-colon-and-
rectal-cancer/
14. Franklin ME Jr et al (1996) Prospective comparison of open vs.
laparoscopic colon surgery for carcinoma. Five-year results. Dis
Colon Rectum 39(10 Suppl):S35–S46
15. Feinberg AE, Chesney TR, Acuna SA et al (2017) Oncologic
outcomes following laparoscopic versus open resection of pT4
colon cancer: a systematic review and meta-analysis. Dis Colon
Rectum 60(1):116–125
16. Kang J, Baik SH, Lee KY et al. Outcomes of laparoscopic sur-
gery in pathologic T4 colon cancers compared to those of open
surgery (2016) Int J Colorectal Dis.
17. Kim KY et al (2012) A single surgeon’s experience with 54
consecutive cases of multivisceral resection for locally advanced
primary colorectal cancer: can the laparoscopic approach be
performed safely? Surg Endosc 26(2):493–500
18. Lacy AM et al (2002) Laparoscopy-assisted colectomy versus
open colectomy for treatment of non-metastatic colon cancer: a
randomised trial. Lancet 359(9325):2224–2229
19. Vignali A et al (2013) Laparoscopic treatment of advanced
colonic cancer: a case-matched control with open surgery.
Colorectal Dis 15(8):944–948
20. Scheidbach H, Garlipp B, Oberla¨nder H et al (2011) Conversion
in laparoscopic colorectal cancer surgery: impact on short- and
long-term outcome. J Laparoendosc Adv Surg Tech A
21:923–927
21. Franko J et al (2008) Conversion of laparoscopic colon resection
does not affect survival in colon cancer. Surg Endosc 22(12):
2631–2634
22. Allaix ME et al (2013) Does conversion affect short-term and
oncologic outcomes after laparoscopy for colorectal cancer? Surg
Endosc 27(12):4596–4607
23. Li J et al (2015) The impact of laparoscopic converted to open
colectomy on short-term and oncologic outcomes for colon
cancer. J Gastrointest Surg 19(2):335–343
24. Rickert A, Herrle F, Doyon F et al (2013) Influence of conversion
on the perioperative and oncologic outcomes of laparoscopic
resection for rectal cancer compared with primarily open resec-
tion. Surg Endosc 27(12):4675–4683. doi:10.1007/s00464-013-
3108-z
25. Bretagnol F et al (2011) T4 colorectal cancer: is laparoscopic
resection contraindicated? Colorectal Dis 13(2):138–143
26. Lehnert T et al (2002) Multivisceral resection for locally
advanced primary colon and rectal cancer: an analysis of prog-
nostic factors in 201 patients. Ann Surg 235(2):217–225
27. Nakafusa Y et al (2004) Comparison of multivisceral resection
and standard operation for locally advanced colorectal cancer:
analysis of prognostic factors for short-term and long-term out-
come. Dis Colon Rectum 47(12):2055–2063
28. Gezen C et al (2012) Results after multivisceral resections of
locally advanced colorectal cancers: an analysis on clinical and
pathological t4 tumors. World J Surg Oncol 10:39
29. Hoffmann M et al (2012) Multivisceral and standard resections in
colorectal cancer. Langenbecks Arch Surg 397(1):75–84
30. Elnahas A, Sunil S, Jackson TD et al (2016) Laparoscopic versus
open surgery for T4 colon cancer: evaluation of margin status.
Surg Endosc 30(4):1491–1496. doi:10.1007/s00464-015-4360-1
31. Kim IY, Kim BR, Kim YW (2016) The short-term and oncologic
outcomes of laparoscopic versus open surgery for T4 colon
cancer. Surg Endosc 30(4):1508–1518. doi:10.1007/s00464-015-
4364-x
1140 Surg Endosc (2018) 32:1133–1140
123
